Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entera Bio Ltd. ([ENTX]) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entera Bio Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1638097.
Total stock buying since 2022: $528,627.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 60,500 | $82,670 | 0 | $0 | 0 | $0 |
| 2025 | 11,000 | $19,910 | 0 | $0 | 0 | $0 |
| 2024 | 17,115 | $15,268 | 0 | $0 | 0 | $0 |
| 2023 | 155,904 | $111,304 | 0 | $0 | 0 | $0 |
| 2022 | 188,223 | $299,475 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-02 | 60,500 | $82,670 | 0 | $0 | 0 | $0 |
| 2025-12 | 11,000 | $19,910 | 0 | $0 | 0 | $0 |
| 2024-01 | 17,115 | $15,268 | 0 | $0 | 0 | $0 |
| 2023-12 | 47,904 | $34,010 | 0 | $0 | 0 | $0 |
| 2023-08 | 78,000 | $46,994 | 0 | $0 | 0 | $0 |
| 2023-04 | 30,000 | $30,300 | 0 | $0 | 0 | $0 |
| 2022-11 | 80,000 | $42,500 | 0 | $0 | 0 | $0 |
| 2022-07 | 34,391 | $57,209 | 0 | $0 | 0 | $0 |
| 2022-01 | 73,832 | $199,766 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-12 | Rubin Steven D | Buy | 5,000 | 1.49 | 7,450 |
| 2026-02-10 | Taitel Haya | Buy | 7,500 | 1.48 | 11,100 |
| 2026-02-10 | Germano Geno J | Buy | 20,000 | 1.49 | 29,800 |
| 2026-02-09 | Ellis Sean | Buy | 18,000 | 1.24 | 22,320 |
| 2026-02-09 | Rubin Steven D | Buy | 10,000 | 1.20 | 12,000 |
| 2025-12-29 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 11,000 | 1.81 | 19,910 |
| 2024-01-12 | Taitel Haya | Buy | 9,500 | .99 | 9,405 |
| 2024-01-10 | Taitel Haya | Buy | 7,615 | .77 | 5,863 |
| 2023-12-22 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 23,952 | .71 | 17,005 |
| 2023-12-22 | Lieberman Gerald M | Buy | 23,952 | .71 | 17,005 |
| 2023-08-22 | Taitel Haya | Buy | 18,000 | .62 | 11,214 |
| 2023-08-21 | Ellis Sean | Buy | 40,000 | .60 | 24,000 |
| 2023-08-21 | Lieberman Gerald M | Buy | 20,000 | .59 | 11,780 |
| 2023-04-04 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 30,000 | 1.01 | 30,300 |
| 2022-11-11 | Ellis Sean | Buy | 30,000 | .53 | 15,900 |
| 2022-11-11 | Toledano Miranda Jayne (Chief Executive Officer) | Buy | 50,000 | .53 | 26,600 |
| 2022-07-21 | Ellis Sean | Buy | 14,900 | 1.64 | 24,406 |
| 2022-07-21 | Lieberman Gerald M | Buy | 19,491 | 1.68 | 32,803 |
| 2022-01-20 | Schwartz Phillip (President of R&D) | Buy | 10,000 | 2.52 | 25,250 |
| 2022-01-19 | Ratan Ramesh (U.S.based CFO) | Buy | 10,000 | 2.44 | 24,360 |
| 2022-01-18 | Ellis Sean | Buy | 10,000 | 2.81 | 28,050 |
| 2022-01-18 | Mayron Ron | Buy | 7,000 | 2.80 | 19,600 |
| 2022-01-18 | Lieberman Gerald M | Buy | 2,800 | 2.80 | 7,839 |
| 2022-01-18 | Jamas Spiros (Chief Executive Officer) | Buy | 10,000 | 2.85 | 28,500 |
| 2022-01-14 | Toledano Miranda Jayne | Buy | 6,800 | 2.79 | 18,972 |
| 2022-01-13 | Malca Yonatan | Buy | 7,232 | 2.74 | 19,815 |
| 2022-01-13 | Ostrov Gerald M | Buy | 10,000 | 2.74 | 27,380 |
Insider trading activities including stock purchases, stock sales, and option exercises of [ENTX] listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entera Bio Ltd. (symbol [ENTX], CIK number 1638097) see the Securities and Exchange Commission (SEC) website.